title: [Therapeutic effect of capsule xinganbao on schistosomal hepatocirrhosis].
abstract: A total of 118 patients with schistosomal hepatocirrhosis were divided into an experiment group (62 cases) and a control group (56 cases), and the former received capsule Xinganbao and the latter received conventional medicine for 6 months. The reductions of serum HA, LN and PCIII were more notable in the experiment group than in the control group (P < 0.05). The clinical symptoms, physical signs, and liver function improved in both groups, and there were no significant differences between two groups. In conclusions, capsule Xinganbao has a good effect on hepatic fibrosis.
authors.affiliation: Schistosomal Specialist Hospital of Jianli County, Hubei Province, Jianli 433300, China.
authors.forename: Hong-Xia
authors.initials: HX
authors.lastname: Zhang
authors.forename: Chun-Xia
authors.initials: CX
authors.lastname: Cheng
authors.forename: Jian-Hua
authors.initials: JH
authors.lastname: Yi
mesh_terms: D000328:Adult; D000368:Aged; D002214:Capsules; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D012552:Schistosomiasis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D002214:Capsules; D004365:Drugs, Chinese Herbal